Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck and Company    MRK

MERCK AND COMPANY

(MRK)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Analyst Recommendations on MERCK AND COMPANY
10/31Bristol-Myers posts better-than-expected results, Opdivo growth slows
RE
10/29Merck Raises 2019 Revenue, Adjusted Earnings Guidance
DJ
10/29Merck Posts Higher 3Q Sales
DJ
10/23P&G Adds To Streak Of Sales Increases -- WSJ
DJ
10/15J&J's Courtroom Losses Pile Up -- WSJ
DJ
10/14Johnson & Johnson's Legal Challenges Mount
DJ
09/30AstraZeneca strengthens Lynparza push with prostate cancer data
RE
08/27Celgene, Bristol Clear Way For Merger -- WSJ
DJ
07/30Cancer drug Keytruda, vaccines propel Merck to quarterly profit beat
RE
07/30MERCK AND : Increases Revenue Guidance as Second-Quarter Sales Grow 12%--Update
DJ
07/30Merck Increases Guidance for Revenue, Adjusted Earnings, Lowers GAAP Profit E..
DJ
07/30MERCK AND : Profit Rises, Sales Increase
DJ
07/25Eliquis, Orencia sales propel Bristol-Myers to strong second quarter
RE
07/22MERCK AND : Bayer sells Dr. Scholl's footcare brand to Yellow Wood Partners
RE
06/20Merck Seeks Deals As It Expands Its Cancer Treatments -- WSJ
DJ
06/19Merck Seeks More Deals
DJ
06/18ASTRAZENECA : Lynparza gets EU nod as first-line ovarian cancer maintenance trea..
RE
05/01MERCK AND : Headed for Eighth Day of Gains After 1Q Earnings Beat -- Data Talk
DJ
04/30MERCK AND : raises full-year forecasts as vaccines power profit beat
RE
04/30MERCK AND : Delivers 1Q Sales, Net Profit Beats -- Update
DJ
04/30MERCK AND : Delivers 1Q Sales, Net Profit Beats
DJ
04/25MERCK & CO., INC. : quaterly earnings release
03/20BRISTOL MYERS SQUIBB : Overheard
DJ
03/19If This Is Failure, Show Me Success -- Overheard
DJ
02/25Roche bets $4.3 billion on Spark in gene therapy move
RE
02/01GLOBAL MARKETS LIVE : Nissan, Amazon, Tesla, Airbus…
01/29MERCK & CO., INC. : annual earnings release
2018Merck bolsters animal health unit with $2.4 billion Antelliq purchase
RE
2018Moderna Declines in Market Debut -- WSJ
DJ
2018AstraZeneca 3Q Sales Increased on New Drug Performance -- Update
DJ
2018Glaxo's Shingles Vaccine Gave Earnings a Shot in the Arm
DJ
2018Vaccines and Genzyme help Sanofi keep promise of return to growth
RE
2018Novartis, Pfizer Collaborate on Drugs Targeting Complex Liver Disease
DJ
2018Merck, Bristol-Myers profits rise on cancer drug sales
RE
2018MERCK AND : 3Q Profit Misses Expectations; Company Lowers Guidance for Year
DJ
2018MERCK AND : 3Q Profit, Revenue Miss Analysts' Expectations
DJ
2018Results of Astra's Lynparza Trial Positions It as New Standard -- Update
DJ
2018Pfizer to replace longtime CEO Read with veteran Bourla
RE
2018Pfizer to replace longtime CEO Read with veteran Bourla
RE
2018Roche steps up efficiency drive to take sting out of biosimilars
RE
2018Europe ready to cash in on cheap copies of AbbVie biotech drug
RE
2018Roundup cancer verdict sends Bayer shares sliding
RE
2018Roundup cancer verdict sends Bayer shares sliding
RE
2018Merck profit beats, but Keytruda sales fail to impress
RE
2018MERCK & CO., INC. : half-yearly earnings release
2018Swiss, German drugmakers join U.S. price freeze
RE
2018MERCK AND : to Cut Drug Prices Amid Pressure -- WSJ
DJ
2018MERCK AND : to Limit Drug-Price Increases, Cut Some Prices
DJ
2018HITTING CANCER EARLY : AstraZeneca's bid to outmaneuver rivals
RE
2018Hitting cancer early - AstraZeneca's bid to outmanoeuvre rivals
RE
2018AstraZeneca, Merck eye $1 billion boost from cancer drug success
RE
2018Clamour for GSK shingles shot points to bigger profits
RE
2018AstraZeneca cancer drug hits second goal by extending survival
RE
2018AstraZeneca insists future is bright after big Crestor sales hit
RE
2018Merck KGaA family says unreservedly behind the pharma unit
RE
2018Pfizer first-quarter results miss estimates as key drug sales fall short
RE
2018Pfizer first-quarter results miss estimates as key drug sales fall short
RE
2018Keytruda sales power Merck to quarterly beat
RE
2018Keytruda sales power Merck to quarterly beat
RE
2018MERCK AND : Adjusts Annual Guidance -- Earnings Review
DJ
2018MERCK & CO., INC. : quaterly earnings release
2018Biosimilar worries takes shine off Roche's guidance hike
RE
2018Currency and pricing squeeze GSK as new shingles vaccine shines
RE
2018New Drug Combinations Improve Survival in Lung Cancer
DJ
2018MERCK AND : Bets Big on Cancer Drug -- WSJ
DJ
2018MERCK AND : Why Merck Is Betting Big on One Cancer Drug
DJ
2018Incyte Shares Tumble After Cancer Drug Fails in Trial With Merck's Keytruda
DJ
2018AstraZeneca Submits Drugs for Approval in U.S., Europe -- Update
DJ
2018Britain's use of copycat biotech drugs takes off while U.S. lags
RE
2018GlaxoSmithKline prescribes commercial reboot for pharma division
RE
2018GlaxoSmithKline prescribes commercial reboot for pharma division
RE
2018AstraZeneca's immunotherapy drug wins key lung cancer approval
RE
2018Bristol-Myers to pay $1.85 billion in cancer deal with Nektar
RE
2018Drug copies ready to take next bite out of Roche's cancer sales
RE
2018AstraZeneca flags return to drug growth in 2018, China shines
RE
1  2  3  4  5  6Next
Upcoming event on MERCK AND COMPANY